Today, the VP, No. American Sales of Align Tech (ALGN), Christopher Puco, sold shares of ALGN for $1.92M.
Following Christopher Puco’s last ALGN Sell transaction on February 24, 2017, the stock climbed by 132.8%. In addition to Christopher Puco, 2 other ALGN executives reported Sell trades in the last month.
See today’s analyst top recommended stocks >>
Based on Align Tech’s latest earnings report for the quarter ending September 30, the company posted quarterly revenue of $505 million and quarterly net profit of $101 million. In comparison, last year the company earned revenue of $385 million and had a net profit of $82.56 million. ALGN’s market cap is $18.39B and the company has a P/E ratio of 61.38. Currently, Align Tech has an average volume of 1.35M.
Based on 11 analyst ratings, the analyst consensus is Strong Buy with an average price target of $329.33, reflecting a 39.7% upside.
The insider sentiment on Align Tech has been negative according to 57 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.
Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Align Technology, Inc. engages in the manufacture, design, and marketing of global medical devices. It operates through the Clear Aligner, and Scanner and Services segments. The Clear Aligner segment consists of invisalign full, teen and assist products, and vivera retainers along with training and ancillary products for treating malocclusion.
